Pay in 4 interest-free payments of $6.08 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
It is not yet FDA approved, but Phase 3 data from the TRIUMPH-4 trial (December 2025) showed an average of 28.7% body weight loss at 68 weeks at the 12 mg dose the highest ever recorded in a pharmacological weight loss trial
Hydrogen acts as a therapeutic antioxidant by selectively reducing cytotoxic oxygen radicals
Gutmann, C., Zelniker, T
This usually improves over time
TanshinoneIIA ameliorates inflammatory microenvironment of colon cancer cells via repression of microRNA-155
(58) described a positive correlation between body mass index (BMI) and adipose tissue UCP-2 expression
US$ 20.74
US$ 24.25
US$ 26.77
US$ 26.41
